Type 2 and arsenic link

A study has identified the biological mechanism linking long-term arsenic exposure to conditions such as cancer and Type 2 diabetes, which could lead to potential

Read More »

Exenatide for T2 teens

The FDA has approved an extended-release version of the GLP-1 drug exenatide for older children and teenagers with Type 2 diabetes, Andrew Briskin report for

Read More »